The Relative Strength (RS) Rating for MaxLinear (MXL) stock jumped into a new percentile Monday, with a rise from 76 to 83.
↑ XIBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they launch their biggest price moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
MaxLinear stock reclaimed its 200-day moving average in early December and has been rallying. While MaxLinear stock is not near a proper buying range right now, see if it manages to form and break out of a proper chart pattern.
The fabless chipmaker reported 0% earnings growth last quarter. Revenue increased -40%.
MaxLinear stock holds the No. 24 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom (AVGO), SiTime (SITM) and NVIDIA (NVDA) are among the top 5 highly rated stocks within the group. For more industry news, check out "Chip Stocks To Watch And Semiconductor Industry News."
YOU MAY ALSO LIKE:
Learn How To Time The Market With IBD's ETF Market Strategy
Find Today's Best Growth Stocks To Watch With IBD 50
Find The Best Long-Term Investments With IBD Long-Term Leaders
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.